QUARTERLY RESULTS
Dr. Reddy's Laboratories Ltd.
BSE
Apr 30
1183.00
+6.75 (+ 0.57%)
Volume
44575
Prev. Close
1176.25
Open Price
1176.25
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
1183.90
+7.90 (+ 0.67%)
Volume
1604442
Prev. Close
1176.00
Open Price
1176.20
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Quarterly Results
for the last 5 years.
|
ISIN No
|
INE089A01031
|
Market Cap. ( ₹ in Cr. )
|
98791.17
|
P/BV
|
3.21
|
Book Value ( ₹ )
|
368.50
|
|
BSE Code
|
500124
|
52 Week High/Low ( ₹ )
|
1421/1020
|
FV/ML
|
1/1
|
P/E(X)
|
17.71
|
|
NSE Code
|
DRREDDYEQ
|
Book Closure
|
28/10/2024
|
EPS ( ₹ )
|
66.84
|
Div Yield (%)
|
0.68
|
(₹ in Crs.)
| Net Sales/Income from operations | 5015.00 | 6696.30 | 5841.20 | 5081.80 | 4103.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 23.00 | 0.00 |
| Total Income From Operations | 5015.00 | 6696.30 | 5841.20 | 5104.80 | 4103.00 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1011.70 | 934.30 | 911.10 | 907.70 | 818.70 |
| Purchase of Traded Goods | 508.40 | 656.50 | 740.30 | 546.30 | 556.90 |
| Increase/Decrease in Stocks | -37.00 | -93.00 | -126.10 | -52.00 | -65.10 |
| Employees Cost | 794.40 | 840.10 | 855.90 | 779.50 | 782.30 |
| Depreciation | 265.10 | 260.00 | 249.80 | 246.20 | 246.40 |
| Provisions And Contingencies | 0.00 | 0.00 | 0.00 | 26.00 | 0.00 |
| Other Expenses | 1545.10 | 1636.80 | 1507.00 | 1518.70 | 1353.90 |
| Total Expenses | 4087.70 | 4234.70 | 4138.00 | 3972.40 | 3693.10 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 927.30 | 2461.60 | 1703.20 | 1132.40 | 409.90 |
| Other Income | 235.40 | 207.60 | 217.80 | 212.70 | 227.60 |
| P/L Before Interest, Excpt. Items & Tax | 1162.70 | 2669.20 | 1921.00 | 1345.10 | 637.50 |
| Interest | 43.30 | 28.40 | 7.10 | 5.90 | 5.60 |
| P/L Before Exceptional Items & Tax | 1119.40 | 2640.80 | 1913.90 | 1339.20 | 631.90 |
| P/L Before Tax | 1119.40 | 2640.80 | 1913.90 | 1339.20 | 631.90 |
| Tax | 270.00 | 758.70 | 496.70 | 304.40 | 156.70 |
| P/L After Tax from Ordinary Activities | 849.40 | 1882.10 | 1417.20 | 1034.80 | 475.20 |
| Net Profit/Loss For the Period | 849.40 | 1882.10 | 1417.20 | 1034.80 | 475.20 |
| | | | | | |
| Equity Share Capital | 83.40 | 83.40 | 83.40 | 83.40 | 83.40 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 10.20 | 112.84 | 85.10 | 62.14 | 28.55 |
| Diluted EPS (Rs.) | 10.18 | 112.84 | 84.97 | 62.04 | 28.50 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 10.20 | 112.84 | 85.10 | 62.14 | 28.55 |
| Diluted EPS (Rs.) | 10.18 | 112.84 | 84.97 | 62.04 | 28.50 |
| | | | | | |
| PBITOE Margin (%) | 18.49 | 36.76 | 29.15 | 22.18 | 9.99 |
| PBTE Margin (%) | 22.32 | 39.43 | 32.76 | 26.23 | 15.40 |
| PBT Margin (%) | 22.32 | 39.43 | 32.76 | 26.23 | 15.40 |
| PAT Margin (%) | 16.93 | 28.10 | 24.26 | 20.27 | 11.58 |